Literature DB >> 18077152

Childhood cancer survival in France, 1990-1999.

Emmanuel Desandes1, Claire Berger, Isabelle Tron, François Demeocq, Stéphanie Bellec, Pascale Blouin, Léonie Casagranda, Lionel De Lumley, Fernand Freycon, Aurélie Goubin, Edouard Le Gall, Danièle Sommelet, Brigitte Lacour, Jacqueline Clavel.   

Abstract

The aim of this study was to describe the overall survival after childhood cancer in France using follow-up data from regional population-based registries. The survival of children (aged under 15 years) diagnosed with a cancer during 1990-1999 was analysed. For all cancers, the survivals were, respectively, 90.3% [89.4-91.3] at 1-year, 75.2% [73.8-76.6] at 5 years and 72.2% [70.7-73.7] at 10 years. During the 1990s, the average improvement in the 5-year survival was +1.2% per year. Adjusted for gender, age, area of residence and stage, children with cancer diagnosed between 1995 and 1999 had a 0.80 reduced risk of dying compared with those whose cancer had been diagnosed between 1990 and 1994. The increase of survival at the population level reflects a global improvement in childhood cancer care. The Paediatric Registries, in association with the French Society of Childhood Cancer, are now collecting data to quantify on a national basis the other events, at least relapse and second cancers.

Entities:  

Mesh:

Year:  2008        PMID: 18077152     DOI: 10.1016/j.ejca.2007.11.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Population-based survival estimates for childhood cancer in Australia during the period 1997-2006.

Authors:  P D Baade; D R Youlden; P C Valery; T Hassall; L Ward; A C Green; J F Aitken
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

2.  Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors.

Authors:  Emmanuel Desandes; Sandra Guissou; Pascal Chastagner; Brigitte Lacour
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

3.  Pathological confirmation of primary lung cancer following breast cancer.

Authors:  M Tennis; B Singh; A Hjerpe; M Prochazka; K Czene; P Hall; P G Shields
Journal:  Lung Cancer       Date:  2009-09-10       Impact factor: 5.705

4.  A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer.

Authors:  Lene H S Veiga; Jay H Lubin; Harald Anderson; Florent de Vathaire; Margaret Tucker; Parveen Bhatti; Arthur Schneider; Robert Johansson; Peter Inskip; Ruth Kleinerman; Roy Shore; Linda Pottern; Erik Holmberg; Michael M Hawkins; M Jacob Adams; Siegal Sadetzki; Marie Lundell; Ritsu Sakata; Lena Damber; Gila Neta; Elaine Ron
Journal:  Radiat Res       Date:  2012-08-02       Impact factor: 2.841

5.  Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors.

Authors:  Ryan Koshy Mathew; Roddy O'Kane; Roger Parslow; Charles Stiller; Tom Kenny; Susan Picton; Paul Dominic Chumas
Journal:  Neuro Oncol       Date:  2014-05-05       Impact factor: 12.300

6.  Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome.

Authors:  Jean-Francois Brasme; Jacques Grill; Francois Doz; Brigitte Lacour; Dominique Valteau-Couanet; Stephan Gaillard; Olivier Delalande; Nozar Aghakhani; Stéphanie Puget; Martin Chalumeau
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

7.  Worldwide Trends in Survival From Common Childhood Brain Tumors: A Systematic Review.

Authors:  Fabio Girardi; Claudia Allemani; Michel P Coleman
Journal:  J Glob Oncol       Date:  2019-10

8.  Survival rate of childhood leukemia in shiraz, southern iran.

Authors:  Almasi-Hashiani Amir; Zareifar Soheil; Karimi Mehran; Khedmati Esmaeil; Mohammadbeigi Abolfazl
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.